glp-1 kidney disease Real-World Evidence for Receptor Agonists Across the CKD Spectrum – AJKD Blog Unlocking Cardio-Renal Protection: Breakthrough with

GLP-1RAs have now become a part of an emerging treatment approach for obesity, with liraglutide being the first GLP-1RA approved by the US Food and Drug Administration (FDA) in December 2014

The frequency of administration varies depending on the specific medication , with some requiring daily injections while others are administered weekly

(KFFs report says 12 states and not 13 because it was released before North Carolina began covering the drugs for obesity.) The report notes that South Carolina plans to add coverage for obesity at the end of 2024, and Connecticut has a legislative mandate to add coverage but it has not yet been implemented

Patients experiencing persistent changes should consult their healthcare providers, who can: Monitor hormone levels Adjust medication dosage if needed Recommend appropriate management strategies The relationship between Ozempic or Wegovy and hormonal function continues to be studied, with research showing both direct and indirect effects on the endocrine system

The goal isn't perfectionit's creating meals that are nourishing, satisfying, and easy enough to stick with